| Literature DB >> 22342142 |
Xicheng Sun1, Jian Qiu, Sarah A Strong, Louis S Green, Jan W F Wasley, Joan P Blonder, Dorothy B Colagiovanni, Adam M Stout, Sarah C Mutka, Jane P Richards, Gary J Rosenthal.
Abstract
The enzyme S-nitrosoglutathione reductase (GSNOR) is a member of the alcohol dehydrogenase family (ADH) that regulates the levels of S-nitrosothiols (SNOs) through catabolism of S-nitrosoglutathione (GSNO). GSNO and SNOs are implicated in the pathogenesis of many diseases including those in respiratory, gastrointestinal, and cardiovascular systems. The pyrrole based N6022 was recently identified as a potent, selective, reversible, and efficacious GSNOR inhibitor which is currently in clinical development for acute asthma. We describe here the synthesis and structure-activity relationships (SAR) of novel pyrrole based analogs of N6022 focusing on carboxamide modifications on the pendant N-phenyl moiety. We have identified potent and novel GSNOR inhibitors that demonstrate efficacy in an ovalbumin (OVA) induced asthma model in mice. Copyright ÂEntities:
Mesh:
Substances:
Year: 2012 PMID: 22342142 DOI: 10.1016/j.bmcl.2012.01.047
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823